cannabidiol Epidiolex Lennox-Gastaut
Selected indexed studies
- Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. (N Engl J Med, 2018) [PMID:29768152]
- Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches. (Epilepsia Open, 2025) [PMID:39700524]
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. (Lancet, 2018) [PMID:29395273]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Epilepsy and cannabidiol: a guide to treatment. (2020) pubmed
- Cannabidiol Adverse Effects and Toxicity. (2019) pubmed
- Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. (2024) pubmed
- Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches. (2025) pubmed
- Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. (2018) pubmed
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. (2018) pubmed
- PMID:39312611 (2024) pubmed
- Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. (2021) pubmed
- PMID:38985911 (2024) pubmed
- CBD in the Treatment of Epilepsy. (2024) pubmed